Recent evidence suggests that nitric oxide (NO), a free radical gas, plays an important role in regulating the function of a variety of neuroendocrine systems. With respect to the hypothalamo-pituitary-gonadal axis, a stimulatory effect of NO on the release of gonadotropin-releasing hormone (GnRH) from rat hypothalamus has been demonstrated in vitro. However, no previous study has reported NO-stimulated secretion of GnRH from in vivo hypothalamus, and also the precise cellular site of action of NO within the GnRH neuronal system remains to be elucidated. In the present study, utilizing the push-pull perfusion technique of rat hypothalamus, we examined the effect of L-arginine (L-Arg), an NO donor, on the release of GnRH, neuropeptide Y and cyclic GMP (c-GMP), which is a pivotal second messenger molecule of the NO system. For comparison, we also examined the effect of carbon monoxide (CO), another putative gaseous neurotransmitter, using hematin, a CO donor. During the period of 11.00–18.00 h, we collected blood and hypothalamic perfusates from ovariectomized adult rats that had been implanted with an estradiol capsule 2 days before. During the entire period of observation, L-Arg (1.0 or 10 mM), hematin (10 or 100 µM) or artificial cerebrospinal fluid alone (as the control) was infused into the medial preoptic area (MPOA) where there are cell bodies of GnRH neurons, or the median eminence-arcuate nucleus complex (ME-ARC) where axon terminals of GnRH neurons are localized. Although 10 mM of L-Arg significantly stimulated GnRH and c-GMP, but not neuropeptide Y, levels in both the MPOA and ME-ARC, GnRH and c-GMP in the ME-ARC were already increased by 1.0 mM of L-Arg. By contrast, both concentrations of hematin were without effect at either site of the hypothalamus. This study is the first to demonstrate that NO is capable of stimulating GnRH release from rat hypothalamus in vivo. Our data also suggests that both cell bodies and axon terminals of GnRH neurons may be sites of action of NO. Our data do not support a previous study by other investigators that reported a stimulatory effect of CO on the GnRH release.

Keywords:
Nitric oxide, Carbon monoxide, Gonadotropins, Gonadotropin-releasing hormone, Neuropeptide Y, Gonadal steroids
1.
Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002–2012.
2.
Brann DW, Bhat GK, Lamar CA, Mahesh VB: Gaseous transmitters and neuroendocrine regulation. Neuroendocrinology 1997;65:385–395.
3.
Nelson RJ, Kriegsfeld LJ, Dawson VL, Dawson TM: Effects of nitric oxide on neuroendocrine function and behavior. Front Neuroendocrinol 1997;18:463–491.
4.
Bonavera JJ, Kalra PS, Kalra SP: L-Arginine/nitric oxide amplifies the magnitude and duration of the luteinizing hormone surge induced by estrogen: Involvement of neuropeptide Y. Endocrinology 1996;137:1956–1962.
5.
Moretto M, López FJ, Negro-Vilar A: Nitric oxide regulates luteinizing hormone-releasing hormone secretion. Endocrinology 1993;133:2399–2402.
6.
Rettori V, Belova N, Dees WL, Nyberg CL, Gimeno M, McCann SM: Role of nitric oxide in the control of luteinizing hormone-releasing hormone release in vivo and in vitro. Proc Natl Acad Sci USA 1993;90:10130–10134.
7.
Bonavera JJ, Sahu A, Kalra PS, Kalra SP: Evidence that nitric oxide may mediate the ovarian steroid-induced luteinizing hormone surge: Involvement of excitatory amino acids. Endocrinology 1993;133:2481–2487.
8.
Bonavera JJ, Sahu A, Kalra PS, Kalra SP: Evidence in support of nitric oxide (NO) involvement in the cyclic release of prolactin and LH surges. Brain Res 1994;660:175–179.
9.
Aguan K, Mahesh VB, Ping L, Bhat G, Brann DW: Evidence for a physiological role for nitric oxide in the regulation of the LH surge: Effect of central administration of antisense oligonucleotides to nitric oxide synthase. Neuroendocrinology 1996;64:449–455.
10.
Dawson TM, Snyder SH: Gases as biological messengers: Nitric oxide and carbon monoxide in the brain. J Neurosci 1994;14:5147–5159.
11.
Lamar CA, Mahesh VB, Brann DW: Regulation of gonadotrophin-releasing hormone (GnRH) secretion by heme molecules: A regulatory role for carbon monoxide? Endocrinology 1996;137:790–793.
12.
Watanobe H, Sasaki S, Takebe K: Evidence that intravenous administration of interleukin-1 stimulates corticotropin releasing hormone secretion in the median eminence of freely moving rats: Estimation by push-pull perfusion. Neurosci Lett 1991;133:7–10.
13.
Watanobe H, Takebe K: Evidence that neuropeptide Y secretion in the median eminence increases prior to the luteinizing hormone surge in ovariectomized steroid-primed rats: Estimation by push-pull perfusion. Neurosci Lett 1992;146:57–59.
14.
Watanobe H, Takebe K: Intravenous administration of tumor necrosis factor-alpha stimulates corticotropin releasing hormone secretion in the push-pull cannulated median eminence of freely moving rats. Neuropeptides 1992;22:81–84.
15.
Watanobe H, Takebe H: Intrahypothalamic perfusion with interleukin-1-beta stimulates the local release of corticotropin-releasing hormone and arginine vasopressin and the plasma adrenocorticotropin in freely moving rats: A comparative perfusion of the paraventricular nucleus and the median eminence. Neuroendocrinology 1993;57:593–599.
16.
Watanobe H, Takebe K: In vivo release of neurotensin from the median eminence of ovariectomized estrogen-primed rats as estimated by push-pull perfusion: Correlation with luteinizing hormone and prolactin surges. Neuroendocrinology 1993;57:760–764.
17.
Watanobe H, Takebe K: Effects of intravenous administration of interleukin-1-beta on the release of prostaglandin E2, corticotropin-releasing factor, and arginine vasopressin in several hypothalamic areas of freely moving rats: Estimation by push-pull perfusion. Neuroendocrinology 1994;60:8–15.
18.
Kalra SP, Kalra PS: Nutritional infertility: The role of the interconnected hypothalamic neuropeptide Y-galanin-opioid network. Front Neuroendocrinol 1996;17:371–401.
19.
Pellegrino LJ, Pellegrino AS, Cushman AJ: A Stereotaxic Atlas of the Rat Brain. New York, Plenum Press, 1979.
20.
Levine JE, Ramirez VD: In vivo release of luteinizing hormone-releasing hormone estimated with push-pull cannulae from the mediobasal hypothalami of ovariectomized, steroid-primed rats. Endocrinology 1980;107:1782–1790.
21.
Watanobe H, Sasaki S, Takebe K: Vasoactive intestinal peptide levels in the hypothalamus and anterior pituitary do not change in association with the preovulatory prolactin surge in the rat. Neuropeptides 1991;20:159–162.
22.
Bhat G, Mahesh VB, Auguan K, Brann DW: Evidence that brain nitric oxide synthase is the major nitric oxide synthase isoform in the hypothalamus of the adult female rat and that nitric oxide potently regulates hypothalamic cGMP levels. Neuroendocrinology 1996;64:93–102.
23.
Bhat GK, Mahesh VB, Lamar CA, Ping L, Aguan K, Brann DW: Histochemical localization of nitric oxide neurons in the hypothalamus: Association with gonadotropin-releasing hormone neurons and co-localization with N-methyl-D-aspartate receptors. Neuroendocrinology 1995;62:187–197.
24.
Grossman AB, Rossmanith WG, Kabigting EB, Cadd G, Clifton D, Steiner RA: The distribution of hypothalamic nitric oxide synthase mRNA in relation to gonadotropin-releasing hormone neurons. J Endocrinol 1994;140: R5–8.
25.
López FJ, Moretto M, Merchenthaler I, Negro Vilar A: Nitric oxide is involved in the genesis of pulsatile LHRH secretion from immortalized LHRH neurons. J Neuroendocrinol 1997;9:647–654.
26.
Tsuruo Y, Kawano H, Kagotani Y, Hisano S, Daikoku S, Chihara K, Zhang T, Yanaihara N: Morphological evidence for neuronal regulation of luteinizing hormone-releasing hormone-containing neurons by neuropeptide Y in the rat septo-preoptic area. Neurosci Lett 1990;110:261–266.
27.
Sahu A, Kalra SP, Crowley WR, Kalra PS: Evidence that NPY-containing neurons in the brainstem project into selected hypothalamic nuclei: Implication in feeding behavior. Brain Res 1988;457:376–378.
28.
Levine JE: New concepts of the neuroendocrine regulation of gonadotropin surges in rats. Biol Reprod 1997;56:293–302.
29.
Bauer-Dantoin AC, McDonald JK, Levine JE: Neuropeptide Y potentiates luteinizing hormone (LH)-releasing hormone-induced LH secretion only under conditions leading to preovulatory LH surges. Endocrinology 1992;131:2946–2952.
30.
Bauer-Dantoin AC, Tabesh B, Norgle JR, Levine JE: RU486 administration blocks neuropeptide Y potentiation of luteinizing hormone (LH)-releasing hormone-induced LH surges in proestrous rats. Endocrinology 1993;133:2418–2423.
31.
Lee WS, Smith MS, Hoffman GE: Progesterone enhances the surge of luteinizing hormone by increasing the activation of luteinizing hormone-releasing hormone neurons. Endocrinology 1990;127:2604–2606.
32.
Lee WS, Smith MS, Hoffman GE: c-FOS activity identifies recruitment of luteinizing hormone-releasing hormone neurons during the ascending phase of the proestrous luteinizing hormone surge. J Neuroendocrinol 1992;4:161–166.
33.
Sabatino FD, Collins P, McDonald JK: Investigation of the effects of progesterone on neuropeptide Y-stimulated luteinizing hormone-releasing hormone secretion from the median eminence of ovariectomized and estrogen-treated rats. Neuroendocrinology 1990;52:600–607.
34.
Parkes D, Kaschkow J, Vale W: Carbon monoxide modulates secretion of corticotropin-releasing factor from rat hypothalamic cell cultures. Brain Res 1994;646:315–318.
35.
Pozzoli G, Mancuso C, Mirtella A, Preziosi P, Grossman AB, Navarra P: Carbon monoxide as a novel neuroendocrine modulator: Inhibition of stimulated corticotropin-releasing hormone release from acute rat hypothalamic explants. Endocrinology 1994;135:2314–2317.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.